Evidence map›Paper›PMID 34093823›Full record

ArticleJournal of Cancer2021

High Expression of RhoBTB3 Predicts Favorable Chemothrapy Outcomes in non-M3 Acute Myeloid Leukemia.

Shuang-Hui Yang, Wei Liu, Jie Peng, Ya-Jing Xu, Yan-Feng Liu, Yan Li, Min-Yuan Peng, Zhao Ou-Yang, Cong Chen, En-Yi Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shuang-Hui YangDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Wei LiuDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Jie PengDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Ya-Jing XuDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Yan-Feng LiuDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Yan LiDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Min-Yuan PengDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Zhao Ou-YangDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Cong ChenDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
En-Yi LiuDepartment of Hematology, XiangYa Hospital, Central South University, XiangYa Road No.87, Changsha 410008, China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute myeloid leukemiaprognostic valueRhoBTB3Rho family GTPasesTCGA

Identifiers

PMID34093823
PMCPMC8176412
OpenAlexW3171503830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.